These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3833531)

  • 41. Surgical management of acromegaly.
    Fahlbusch R; Honegger J; Buchfelder M
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):669-92. PubMed ID: 1521518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
    Starke RM; Raper DM; Payne SC; Vance ML; Oldfield EH; Jane JA
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transsphenoidal microhypophysectomy in acromegaly.
    U HS; Wilson CB; Tyrrell JB
    J Neurosurg; 1977 Dec; 47(6):840-52. PubMed ID: 925741
    [No Abstract]   [Full Text] [Related]  

  • 46. [Functional results of transsphenoidal selective adenomectomy in acromegaly (40 cases)].
    Stevenaert A; Chiodera P; Legros JJ; Copinschi G; Franchimont P
    Ann Endocrinol (Paris); 1980; 41(3):249-50. PubMed ID: 7416713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors affecting the outcome of surgical treatment of acromegaly.
    Er LK; Chang TC; Lin SM; Huang KM; Chang CC
    J Formos Med Assoc; 2000 Mar; 99(3):191-8. PubMed ID: 10820950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
    Bellut D; Hlavica M; Schmid C; Bernays RL
    Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery?
    van den Berg G; van Dulken H; Frölich M; Meinders AE; Roelfsema F
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):45-51. PubMed ID: 9797846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Transsphenoidal surgery in hypersecreting pituitary tumors: endocrine follow-up (author's transl)].
    Guibout M; Jaquet P; Lissitzky JC; Grisoli F; Vincentelli F
    Ann Endocrinol (Paris); 1978; 39(2):95-106. PubMed ID: 687397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH; Oh MC; Lee EJ; Kim SH
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
    Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
    J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel use of endogenous GH-measurement directly after transsphenoidal microsurgery in acromegaly treated with pegvisomant.
    Lüdecke DK; Crock PA; Bidlingmaier M; Schuppert F
    Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):509-12. PubMed ID: 23765756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of acromegaly by transsphenoidal surgery.
    Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
    Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth-hormone-binding protein in patients with acromegaly.
    Amit T; Ish-Shalom S; Glaser B; Youdim MB; Hochberg Z
    Horm Res; 1992; 37(6):205-11. PubMed ID: 1292973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
    Nyquist P; Laws ER; Elliott E
    Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acromegaly. Treatment by transsphenoidal microsurgery.
    Atkinson RL; Becker DP; Martins AN; Schaaf M; Dimond RC; Wartofsky L; Earll JM
    JAMA; 1975 Sep; 233(12):1279-83. PubMed ID: 1174188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.
    Nomikos P; Buchfelder M; Fahlbusch R
    Eur J Endocrinol; 2005 Mar; 152(3):379-87. PubMed ID: 15757854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transphenoidal microsurgery for acromegaly. Successful treatment with preservation of pituitary function.
    Becker DP; Atkinson R; Sakalas R; Vries JK; Young HF; Vines FS; Martinez J
    Confin Neurol; 1974; 36(2):101-5. PubMed ID: 4824576
    [No Abstract]   [Full Text] [Related]  

  • 60. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.
    Abosch A; Tyrrell JB; Lamborn KR; Hannegan LT; Applebury CB; Wilson CB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3411-8. PubMed ID: 9768640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.